2. Academic Validation
  3. Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine

Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine

  • Nat Rev Drug Discov. 2020 Jul;19(7):480-494. doi: 10.1038/s41573-020-0070-z.
Anwesha Dey 1,  Xaralabos Varelas 2,  Kun-Liang Guan 3
Affiliations

Affiliations

  • 1 Department of Discovery Oncology, Genentech, Inc., South San Francisco, CA, USA. dey.anwesha@gene.com.
  • 2 Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA. xvarelas@bu.edu.
  • 3 Department of Pharmacology and Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
PMID: 32555376 DOI: 10.1038/s41573-020-0070-z
Abstract

The Hippo pathway is an evolutionarily conserved signalling pathway with key roles in organ development, epithelial homeostasis, tissue regeneration, wound healing and immune modulation. Many of these roles are mediated by the transcriptional effectors YAP and TAZ, which direct gene expression via control of the TEAD family of transcription factors. Dysregulated Hippo pathway and YAP/TAZ-TEAD activity is associated with various diseases, most notably Cancer, making this pathway an attractive target for therapeutic intervention. This Review highlights the key findings from studies of Hippo pathway signalling across biological processes and diseases, and discusses new strategies and therapeutic implications of targeting this pathway.

Figures